When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 25 Hits
  • Search Condition : Filter (MeSH = Antibodies, Monoclonal / pharmacology*)
Species Resource Title
Human and Animal Cells TT1TKB(RCB1185) A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Human and Animal Cells OCUB-F(RCB0882) Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1.
Human and Animal Cells CHO-K1 Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
Human and Animal Cells A20(RCB2745) Development of a simple new flow cytometric antibody-dependent cellular cytotoxicity (ADCC) assay with excellent sensitivity.
DNA material pENTER-EGFR wild-type (RDB15488) , pENTER-EGFR Del19 (RDB15489) , pENTER-EGFR T790M/del19 (RDB15490) , pENTER-EGFR C797S/del19 (RDB15491) , pENTER-EGFR C797S/T790M/del19 (RDB15492) , pENTER-EGFR L858R (RDB15493) , pENTER-EGFR T790M/L858R (RDB15494) , pENTER-EGFR C797S/L858R (RDB15495) , pENTER-EGFR C797S/T790M/L858R (RDB15496). Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.
Human and Animal Cells Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
Human and Animal Cells Antibody-mediated targeting of the Orai1 calcium channel inhibits T cell function.
Human and Animal Cells Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma.
Human and Animal Cells Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
Human and Animal Cells Monitoring the cytoskeletal EGF response in live gastric carcinoma cells.
Human and Animal Cells Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines.
Human and Animal Cells Effect of the antibody immunotherapy by the anti-MUC1 monoclonal antibody to the oral squamous cell carcinoma in vitro.
Human and Animal Cells Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity.
Human and Animal Cells Blocking effect of anti-Dectin-1 antibodies on the anti-tumor activity of 1,3-beta-glucan and the binding of Dectin-1 to 1,3-beta-glucan.
Human and Animal Cells Characterization of novel murine anti-CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab).
Human and Animal Cells Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines.
Human and Animal Cells Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Human and Animal Cells Expression of ICAD-l and ICAD-S in human brain tumor and its cleavage upon activation of apoptosis by anti-Fas antibody.
Human and Animal Cells Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.